Clinical Trials & Research
Search Clinical Trials
Clinical Trials
New Search
Title | A Randomized Phase II Study Comparing Single-Agent Olaparib, Single Agent Cediranib, and the Combination of Cediranib/Olaparib in Women With Recurrent, Persistent or Metastatic Endometrial Cancer |
---|---|
Disease/Condition | Obstetrics & Gynecology and Women`s Health,Urologic Oncology (Med Onc),Cancer,Carcinoma,Urogenital Neoplasms |
Description | |
Eligibility Criteria | Click here for eligibility requirements |
Principal Investigator | Nicole Nevadunsky, MD |
Contact Name | Meghan Proehl |
Contact Email | mproehl@montefiore.org |
Protocol Number | 2018-9876 |
Inclusion/Notes | This Information was obtained from ClinicalTrials.gov |
Status | Active/Enrolling |
Adult Clinical Trial | Yes |
Pediatric Clinical Trial | No |
Sub-Specialty | Cancer-Related Endometrial |
Adult, Pediatric, Both | Adult |